CIBC World Market’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$817K Buy
+8,250
New +$743K ﹤0.01% 1064
2025
Q1
Sell
-3,215
Closed -$211K 1404
2024
Q4
$211K Buy
+3,215
New +$221K ﹤0.01% 1283
2019
Q2
Sell
-4,701
Closed -$241K 1179
2019
Q1
$241K Buy
+4,701
New +$234K ﹤0.01% 1034
2018
Q4
Sell
-73,452
Closed -$4.11M 1144
2018
Q3
$4.11M Buy
+73,452
New +$4.01M 0.02% 340
2018
Q2
Sell
-4,650
Closed -$229K 1200
2018
Q1
$229K Hold
4,650
﹤0.01% 1062
2017
Q4
$239K Hold
4,650
﹤0.01% 716
2017
Q3
$242K Hold
4,650
﹤0.01% 681
2017
Q2
$240K Hold
4,650
﹤0.01% 1029
2017
Q1
$234K Sell
4,650
-7,143
-61% -$354K ﹤0.01% 905
2016
Q4
$556K Buy
11,793
+4,413
+60% +$209K ﹤0.01% 758
2016
Q3
$368K Buy
7,380
+144
+2% +$7.3K ﹤0.01% 805
2016
Q2
$348K Sell
7,236
-1,257
-15% -$59.8K ﹤0.01% 740
2016
Q1
$388K Sell
8,493
-4,908
-37% -$230K ﹤0.01% 666
2015
Q4
$722K Sell
13,401
-14,607
-52% -$768K ﹤0.01% 551
2015
Q3
$1.38M Sell
28,008
-18,978
-40% -$1.09M 0.01% 377
2015
Q2
$2.74M Buy
46,986
+16,620
+55% +$971K 0.01% 277
2015
Q1
$1.75M Buy
30,366
+10,482
+53% +$573K 0.01% 325
2014
Q4
$1M Sell
19,884
-11,757
-37% -$573K ﹤0.01% 448
2014
Q3
$1.48M Buy
31,641
+24,108
+320% +$1.09M 0.01% 335
2014
Q2
$339K Buy
7,533
+2,022
+37% +$87K ﹤0.01% 594
2014
Q1
$233K Buy
+5,511
New +$231K ﹤0.01% 653

Other funds holding IHE

CIBC World Market's IHE Position: Q2 2026 in Review

CIBC World Market opened a new position in iShares US Pharmaceuticals ETF (IHE) in Q2 2026: 8,250 shares worth $817K. The stake represents ﹤0.01% of the portfolio and ranks #1064 among its holdings. This is a return to the name: CIBC World Market previously reported a position in IHE as recently as Q4 2024.

CIBC World Market first reported a position in IHE in Q1 2014 and has held it in 21 quarters since. The position peaked at $4.11M in Q3 2018. 210 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

  • CIBC World Market held 8,250 shares of iShares US Pharmaceuticals ETF worth $817K as of Q2 2026.
  • iShares US Pharmaceuticals ETF was a new CIBC World Market position in Q2 2026.
  • iShares US Pharmaceuticals ETF made up ﹤0.01% of CIBC World Market's portfolio in Q2 2026, its #1064 holding.
  • CIBC World Market first reported a position in iShares US Pharmaceuticals ETF in Q1 2014 and has held it in 21 quarters since.
  • CIBC World Market's iShares US Pharmaceuticals ETF position peaked at $4.11M in Q3 2018.
  • 210 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on CIBC World Market's 13F filing for Q2 2026, filed 13 Aug 2026.